5-Bromonicotinic acid can be used as a pharmaceutical intermediate to synthesize 5-aryloyl nicotinic acid compounds. 5-Bromonicotinic acid has the characteristics of good drug similarity, high oral bioavailability, and low toxicity through molecular docking prediction. 5-Bromonicotinic acid has good binding ability with hepatitis virus proteins (binding energy: -4.7 to -5.3 kcal/mol)[1][2].
Molekulargewicht:
202.01
Reinheit:
99.83
CAS Nummer:
[20826-04-4]
Formel:
C6H4BrNO2
Target-Kategorie:
Drug Intermediate
Anwendungsbeschreibung:
MCE Product type: Biochemical Assay Reagents
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten